Division of Research, Kaiser Permanente, Oakland, California 94612, USA.
Clin Gastroenterol Hepatol. 2013 Feb;11(2):172-80. doi: 10.1016/j.cgh.2012.09.010. Epub 2012 Sep 14.
BACKGROUND & AIMS: Reliable community-based colorectal adenoma prevalence estimates are needed to inform colonoscopy quality standards and to estimate patient colorectal cancer risks; however, minimal data exist from populations with large numbers of diverse patients and examiners.
We evaluated the prevalence of adenomas detected by sex, age, race/ethnicity, and colon location among 20,792 Kaiser Permanente Northern California members ≥50 years of age who received a screening colonoscopy examination (102 gastroenterologists, 2006-2008).
Prevalence of detected adenomas increased more rapidly with age in the proximal colon (adjusted odds ratio [OR], 2.39; 95% confidence interval [CI], 2.05-2.80; 70-74 vs 50-54 years) than in the distal colon (OR, 1.89; 95% CI, 1.63-2.19). Prevalence was higher among men vs women at all ages (OR, 1.77; 95% CI, 1.66-1.89), increasing in men from 25% to 39% at ≥70 years and in women from 15% at 50-54 years to 26% (P < .001). Proximal adenoma prevalence was higher among blacks than whites (OR, 1.26; 95% CI, 1.04-1.54), although total prevalence was similar, including persons <60 years old (OR, 1.17; 95% CI, 0.91-1.50).
Prevalence of detected adenomas increases substantially with age and is much higher in men; proximal adenomas are more common among blacks than whites, although the total prevalence and the prevalence for ages <60 years were similar by race. These demographic differences are such that current adenoma detection guidelines may not be valid, without adjustment, for comparing providers serving different populations. The variation in prevalence and location may also have implications for the effectiveness of screening methods in different demographic groups.
可靠的基于社区的结直肠腺瘤患病率估计数据对于制定结肠镜检查质量标准和评估患者结直肠癌风险至关重要;然而,来自具有大量不同患者和检查者的人群的数据很少。
我们评估了 20792 名年龄在 50 岁以上的 Kaiser Permanente 北加利福尼亚分会成员中,由 102 名胃肠病学家在 2006-2008 年间进行筛查性结肠镜检查时,按性别、年龄、种族/民族和结肠部位检测到的腺瘤患病率。
与远端结肠(调整后比值比[OR],1.89;95%置信区间[CI],1.63-2.19)相比,近端结肠(调整后 OR,2.39;95%CI,2.05-2.80;70-74 岁 vs 50-54 岁)中腺瘤的检出率随年龄的增长更为迅速。在所有年龄段,男性的患病率均高于女性(OR,1.77;95%CI,1.66-1.89),≥70 岁男性的患病率从 25%增加到 39%,而 50-54 岁女性的患病率从 15%增加到 26%(P<0.001)。与白人相比,黑人的近端腺瘤患病率更高(OR,1.26;95%CI,1.04-1.54),尽管总患病率相似,包括<60 岁的人群(OR,1.17;95%CI,0.91-1.50)。
检出腺瘤的患病率随年龄显著增加,且男性更高;与白人相比,黑人近端腺瘤更为常见,尽管按种族划分,<60 岁人群的总患病率和患病率相似。这些人口统计学差异表明,如果不进行调整,当前的腺瘤检出指南可能不适用于比较服务于不同人群的提供者。患病率和部位的差异也可能对不同人群的筛查方法的有效性产生影响。